SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-050412
Filing Date
2021-10-07
Accepted
2021-10-07 16:09:55
Documents
14
Period of Report
2021-10-07
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nktx-8k_20211007.htm   iXBRL 8-K 41816
2 EX-99.1 nktx-ex991_6.htm EX-99.1 29181
3 GRAPHIC gaydkcu4t2zi000001.jpg GRAPHIC 13412
  Complete submission text file 0001564590-21-050412.txt   229963

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA nktx-20211007.xsd EX-101.SCH 5669
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE nktx-20211007_lab.xml EX-101.LAB 20078
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nktx-20211007_pre.xml EX-101.PRE 11922
7 EXTRACTED XBRL INSTANCE DOCUMENT nktx-8k_20211007_htm.xml XML 3679
Mailing Address 6000 SHORELINE COURT SUITE 102 SOUTH SAN FRANCISCO CA 94080
Business Address 6000 SHORELINE COURT SUITE 102 SOUTH SAN FRANCISCO CA 94080 415-582-4923
Nkarta, Inc. (Filer) CIK: 0001787400 (see all company filings)

IRS No.: 474515206 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39370 | Film No.: 211312494
SIC: 2834 Pharmaceutical Preparations